Profile photo Helena Verkooijen

Helena Verkooijen

Full Professor

Strategic program(s):

Biography

Professor of Evaluation of Image-Guided Treatment, dedicated to improve the life of people with cancer. Committed to full integration of clinical research in routine patient care in order to facilitate undelayed evidence-based implementation of innovations in oncology. 
Medical-scientific director of the Imaging Cluster (incorporating the departments of Radiology, Radiotherapy, Nuclear Medicine and Clinical Physics) at the Antoni van Leeuwenhoek hospital. Leader (PI) of several international research consortia and academic industrial partnership, based at UMC Utrecht. Strong background in teaching and development of educational modules at graduate and postgraduate level. Large international academic experience in Europe and Asia. Experienced speaker, moderator, panel member, and member of the supervisory board of the Rotterdam Eye Hospital. 
Sharp analytic mind, strong drive and ability to turn ideas into reality. Connector. Passionate about encouraging and facilitating colleagues, team members, and (PhD) students to bring out the best in themselves and each other.

Research groups

Evaluation of imaging and image-guided Interventions

Research aim

The pace of innovation in (AI driven) imaging/image-guided interventions in oncology is high; the window of opportunity for evaluation narrow. We aim to learn from every patient, in order to facilitate evidence-based implementation of innovation.

Go to group

Recent publications

Hyperbaric Oxygen Therapy and Late Local Toxic Effects in Patients With Irradiated Breast Cancer Dieuwke R Mink van der Molen, Marilot C T Batenburg, Wiesje Maarse, Desiree H J G van den Bongard, Annemiek Doeksen, Marjoleine Y de Lange, Carmen C van der Pol, Daniel J Evers, Corine A Lansdorp, Jacco van der Laan, Peter M van de Ven, Femke van der Leij, Helena M Verkooijen
JAMA Oncology, 2024, vol. 10, p.464-474
Quality of life and clinical outcomes in rectal cancer patients treated on a 1.5T MR-Linac within the MOMENTUM study L. A. Daamen, J. M. Westerhoff, A. M. Couwenberg, P. M. Braam, H. Rütten, M. D. den Hartogh, J. P. Christodouleas, W. A. Hall, H. M. Verkooijen, M. P.W. Intven
Clinical and translational radiation oncology, 2024, vol. 45
Stereotactic Body and Conventional Radiotherapy for Painful Bone Metastases Bas J J Bindels, Carole Mercier, Roxanne Gal, Jorrit-Jan Verlaan, Joost J C Verhoeff, Piet Dirix, Piet Ost, Nicolien Kasperts, Yvette M van der Linden, Helena M Verkooijen, Joanne M van der Velden
JAMA network open, 2024, vol. 7, p.1-14
Competing risk analysis of cardiovascular disease risk in breast cancer patients receiving a radiation boost Yvonne Koop, Femke Atsma, Marilot C T Batenburg, Hanneke Meijer, Femke van der Leij, Roxanne Gal, Sanne G M van Velzen, Ivana Išgum, Hester Vermeulen, Angela H E M Maas, Saloua El Messaoudi, Helena M Verkooijen
Cardio-oncology (London, England), 2024, vol. 10
Patient expectation and experience of MR-guided radiotherapy using a 1.5T MR-Linac S R de Mol van Otterloo, J M Westerhoff, T Leer, R H A Rutgers, L T C Meijers, L A Daamen, M P W Intven, H M Verkooijen
Technical innovations & patient support in radiation oncology, 2024, vol. 29
Safety and Tolerability of Online Adaptive High-Field Magnetic Resonance-Guided Radiotherapy Jasmijn M. Westerhoff, Lois A. Daamen, John P. Christodouleas, Erwin L.A. Blezer, Ananya Choudhury, Rosalyne L. Westley, Beth A. Erickson, Clifton D. Fuller, Shaista Hafeez, Uulke A. Van Der Heide, Martijn P.W. Intven, Anna M. Kirby, Susan Lalondrelle, Bruce D. Minsky, Stella Mook, Marlies E. Nowee, Corrie A.M. Marijnen, Kristina M. Orrling, Arjun Sahgal, Christopher J. Schultz, Corinne Faivre-Finn, Robbert J.H.A. Tersteeg, Alison C. Tree, Chia-Lin Tseng, Tine Schytte, Dustin M. Silk, Dave Eggert, Marco Luzzara, Jochem R.N. Van Der Voort Van Zyp, Helena M. Verkooijen, William A. Hall
JAMA network open, 2024, vol. 7

External positions

Member Supervisory Board, Oogziekenhuis Rotterdam